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Background: Polycystic ovary syndrome (PCOS) is one of the most
common endocrine disorders among women of reproductive age.
There is evidence for a genetic component in PCOS based on familial
clustering of cases.
Objective: In the present study, the heritability of PCOS was
estimated.
Design/Participants: Data from 1332 monozygotic twins (geneti-
cally identical) and 1873 dizygotic twins/singleton sisters of twins
(who share on average 50% of their segregating genes) registeredwith
The Netherlands Twin Register were used. PCOS was defined as less
than nine menstrual cycles and acne or hirsutism in agreement with
the 2003 Rotterdam consensus.
Results: Results point to a strong contribution of familial factors to
PCOS. The resemblance in monozygotic twin sisters (tetrachoric cor-
relation 0.71) for PCOS was about twice as large as in dizygotic twin
and other sisters (tetrachoric correlation 0.38). Univariate analyses
point to strong contributions of genetic factors to the variance in
PCOS. Next, a trivariate genetic analysis of oligomenorrhea, acne,
and hirsutism was carried out. This analysis confirmed that the
familial component in PCOS is due to genetic factors.
Conclusions: This study demonstrated a large influence of genetic
factors to the pathogenesis of PCOS, justifying the search for sus-
ceptibility genes. (J Clin Endocrinol Metab 91: 2100–2104, 2006)
POLYCYSTIC OVARY SYNDROME (PCOS) is one of themost common endocrine disorders among women of
reproductive age. The prevalence is estimated at 5–10% (1–3).
In 2003 an international consensus on the definition of PCOS
was published (4). PCOS is defined as at least two of the
following symptoms: oligo- or anovulation, hyperandro-
genism (defined as elevated androgen serum levels or hir-
sutism and/or acne), and polycystic ovaries on ultrasound
(4). The finding of polycystic ovaries onultrasonographywas
originally the hallmark for the diagnosis of the syndrome but
represents a sign of a wide variety of disorders and appears
to be a nonspecific finding in approximately 20% of the
asymptotic women (5). The symptoms of PCOS include the
consequences of excessive androgen production, anovula-
tion, and consequently infertility (6). Early identification of
women at risk for PCOS can have profound implications on
prevention of PCOS-associated endocrine disorders.
The pathogenesis of PCOS has not yet been elucidated, but
familial clustering suggests genetic involvement. Studies in
first-degree relatives of women affected by PCOS clearly
indicate genetic influences, but no clear mode of inheritance
has been identified (7, 8). A polygenic multifactorial model
involving multiple genes is most likely (9). To identify genes
playing a role in PCOS, linkage and association analyses
were carried out. For example, a study with 37 candidate
genes in the knownpathways for PCOS showed linkagewith
the follistatin gene and suggestive linkagewith CYP11A (10).
Other studies failed to detect any consistent association be-
tween PCOS and follistatin (11) or CYP11A (12). Other can-
didate genes for PCOS are genes involved in the biosynthesis
and metabolism of androgens, genes involved in folliculo-
genesis, and the secretion and action of insulin (9, 10, 13–15).
So far, no clear estimate of the impact of genes, the heri-
tability of PCOS, is available. Twin-family studies are com-
monly used for this type of investigation. Dizygotic (DZ)
twins, like ordinary siblings, on average share 50% of their
segregating genes, whereas monozygotic (MZ) twins share
all their genes. A higher association for PCOS in MZ twins,
compared with DZ twins and siblings, indicates genetic in-
fluences. Twin data allow distinguishing between the influ-
ence of genetic and environmental factors on phenotypic
variation (16). Genetic influences will lead to larger MZ than
DZ/sister correlations. Environmental influences can be
unique to individuals or can be shared by family members.
Environmental influences shared by sisters growing up in
the same family will lead to MZ, DZ, and sister-pair corre-
lations of equal size. Unique environmental influences will
not cause resemblance among sisters. Using statistical mod-
eling techniques makes it possible to obtain a quantitative
estimate of the genetic and environmental influence on
PCOS. The aim of this study was to estimate the heritability
of PCOS. First, a univariate model including genetic and
environmental influences was fitted to data of Dutch twins
and sisters. PCOS was defined as less than nine menstrual
cycles a year plus acne or hirsutism. In addition, we inves-
tigated oligomenorrhea, acne, and hirsutism in a trivariate
model (Fig. 1). This allowed us to study whether the three
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variables are indicators of a single latent unobserved trait
(PCOS).
Subjects and Methods
Subjects
This study is part of an ongoing twin family study on health-related
behavior in participants of The Netherlands Twin Register (17). With an
interval of 2–3 yr, twins and familymembers receivemailed surveys. For
the purpose of this study, data from the 2000 survey were used (18).
Zygosity was based on (longitudinal) questionnaire data or, when avail-
able, DNA typing (n 572 females). Agreement between zygosity based
on questionnaire data and zygosity based on DNA results is 96%.
In total, 4236 females participated in the 2000 survey. Spouses of male
twins (n 265) and half-siblings (n 17) were excluded. When data on
menstrual cycle were missing (n  726), it was not possible to classify
the subject for PCOS. Data on zygosity were missing for 15 twins. The
remaining data set for the univariate analyses of PCOS contained 3205
females: 1332 MZ twins, 680 DZ (same sex) twins, 474 females from
dizygotic opposite sex pairs, and 719 (nontwin) sisters.
Phenotype definition
PCOSwas defined based on questions about the number ofmenstrual
cycles per year, when not using contraception (with answer categories
more than eight, less than nine, less than six, two or less), about suffering
from acne/pimples (yes or no) and suffering from hirsutism (yes or no).
PCOS was defined as less than nine natural menstrual cycles a year
combined with hirsutism or acne. In addition, the survey provided
information on date of birth, age at menarche, birth weight, current
height and weight, having children, and smoking habits. Characteristics
of participants are listed in Table 1.
Statistical analyses
Modeling of twin data allows discrimination between phenotypic
variance due to genetic factors and environmental factors (19). The
additive genetic effects of contributing gene loci are expressed in the
additive genetic variance reflecting the narrow-sense heritability of
PCOS. Another source of genetic variation is dominance; this is the
extent to which the effects of alleles at a locus do not simply add up but
reflect nonadditive gene action. Variance caused by shared environ-
mental effects is reflected in common environmental variance. Envi-
ronmental effects that are not shared between family members result in
unique environmental variance (e2). This later estimate also includes
measurement error. Therefore, the unique environmental variance is
always specified in the model. Phenotypic similarities in MZ twins can
be due to common environmental and genetic influences. Unique en-
vironmental influences contribute to the differences between MZ twins.
DZ twins, like other siblings, share approximately 50% of their genetic
makeup. The correlation between their additive genetic values is 0.5, and
the correlation between their nonadditive genetic values is 0.25. Com-
mon environmental effects contribute similarly to similarities between
DZ and MZ twins. Adding singleton sisters of twins and females from
FIG. 1. Diagram of the common pathway
model. Ol, Oligomenorrhea (yes/no); Ac, acne
(yes/no); Hi, hirsutism (yes/no); A, additive ge-
netic influences; C, common environment; E,
nonshared environment; As, specific additive
genetic influences; Ds, specific dominant ge-
netic influences; Es, specific unique environ-
ment; parentheses, percentage of the total
variance. The total variance for each variable
is constrained at 1. For example, the total vari-
ance of acne  variance explained by specific
additive genetic factors (72%)  specific
unique environmental factors (21%)  factor
loading of the latent PCOS construct (.07) 
additive genetic influences on PCOS (79%) 
factor loading of the latent PCOS construct
(.07)  unique environmental influences on
PCOS (21%)  72%  21% .0779% 
0.721%  100%.
TABLE 1. Characteristics of the study population
Nine or more
menstrual cycles
(n  2947)
Less than 9
menstrual
cycles (n  258)
P value
MZ twins 1213 119 (8.9%)
DZ twins 1073 81 (7.0%)
Sisters 661 58 (8.1%) 0.540
Acne 30.0% 27.1% 0.326
Hirsutism 8.5% 14.5% 0.001
Age (yr) 29.4 30.1 0.332
Age at first menarche (yr) 13.1 13.4 0.002
Height (cm) 169.9 168.4 0.000
Weight (kg) 65.5 65.8 0.681
Body mass index (kg/m2) 22.7 23.2 0.023
Birth weight (g) 2657 2697 0.545
Having children 33.4% 37.2% 0.213
Current smoker 23.0% 23.0% 0.987
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dizygotic opposite sex twin pairs to the study population enhances the
statistical power for the estimation of the contribution of genetic and
environmental influences (20).
Because the phenotype was a dichotomous variable, a threshold
model was used (21). A categorical characteristic such as PCOS is as-
sumed to have anunderlying liability,which is continuous andnormally
distributed in the population. The liability to PCOS is divided into two
categories, yes and no, separated by a single threshold. The threshold is
obtained from the observed proportions in the two categories. Individ-
uals falling below the threshold do not have PCOS, and those exceeding
the threshold do suffer from PCOS.
Information about twin resemblance in liability is given by tetrachoric
correlations.
Genetic models were applied to raw ordinal data using the Mx sta-
tistical program (22). First, a full model with genetic, common environ-
mental, and unique environmental influences was fitted. Next, the full
model was reduced by excluding the genetic or common environment
component. The reduced models were compared with the full model by
hierarchic 2 tests. The 2 statistic was calculated by subtracting the
2log likelihood of the goodness of fit of a reduced model from the full
model. If the reduced model does not describe the data significantly
worse than the full model, the reduced model can be considered as the
best model. Last, a multivariate model was fitted to the data on oligo-
menorrhea, hirsutism, and acne. To investigate whether the three vari-
ables define a single construct of PCOS, a common pathway model was
applied. This model assumes that all three variables are indicators of a
single latent unobserved trait (PCOS). The relative importance of the
latent trait on the observed variables (oligomenorrhea, hirsutism, and
acne) is indicated by the value of the loadings from the latent factor to
the observed traits. The variance of the latent factors is decomposed into
genetic and environmental components. The variance of the observed
traits that is not attributable to the PCOS factor is also composed into
genetic and environmental components (Fig. 1) (23).
Results
Characteristics of the study population are listed in Table
1. The prevalence for oligomenorrhea varied from 7.0% in
singleton sisters to 8.1% in MZ twins and 8.9% in DZ twins.
The prevalenceswere not significantly different betweenMZ
twins, DZ twins, and singleton sisters (P 0.540). In total, 8%
of the females included in this study reported to have less
than nine menstrual cycles in a year. The percentage of fe-
males suffering from acne was not different for females with
more or less than nine menstrual cycles. In contrast, the
females with less than nine menstrual cycles report more
often to suffer from hirsutism than the females with nine or
more menstrual cycles a year. The two groups also differed
significantly in age at menarche and height and body mass
index but not in current weight and birth weight. There were
92 women (2.9%) classified as having PCOS. The prevalence
was not significantly different for MZ twins, DZ twins, or
singleton sisters (P  0.836).
Table 2 shows the tetrachoric correlations for MZ twin
pairs and DZ twin and sister pairs. The MZ correlations are
higher than the DZ and sister correlations, suggesting a large
genetic influence on all variables. The pattern of correlations
for acne, hirsutism, and PCOS suggest additive genetic in-
fluences (MZ correlation twice as high as the DZ correlation).
For oligomenorrhea, the MZ correlation exceeds more than
twice the DZ correlation, suggesting genetic dominance or
epistasis.
First, univariate genetic models were fitted to the PCOS
data (Table 3). In the full model, 66% of the variance is
explained by genetic factors (additive genetic variance), 12%
by shared environment factors (common environmental
variance), and 29% by unique environmental factors (e2).
Those results suggested that the role of shared environmen-
tal factors is small or nonsignificant. The full model could be
reduced to a model including only genetic factors [a2 72%,
95% confidence interval (CI) 46–88%] and unique environ-
mental factors (e2 28%, 95%CI 12–54%). Next, we explored
whether the shared environmental influence could be
dropped (model 2) and whether both the shared environ-
mental influence and the genetic influence could be dropped
(model 3). The fit of the submodels was compared with the
fit of the full model (2  2LLfull model  2LLsubmodel and
df  dffull model  dfsub-model) to check whether the submod-
els fit the data significantlyworse. The statistical power of the
analyses did not allow distinguishing between model 2 and
model 3 (Table 3) because both models did not significantly
worsen the fit compared to model 1 (P  0.05). The best
model is a model with the smallest number of parameters
necessary to explain the data adequately. The Akaike’s In-
formation Criterion (AIC  2 – 2df) is a measure of the
parsimony of the model and a lower value of AIC indicates
a more parsimonious model. The AIC (in Table 3) indicated
that the model including additive genetic influences and
unique environmental factors was the most parsimonious
model.
In addition, a common pathway model was fitted to the
data. In this model, three variables (oligomenorrhea, hirsut-
ism, and acne) are hypothesized to be indicators of a single
latent phenotype (PCOS). The variation in the latent PCOS
construct is decomposed into additive genetic, common, and
unique environmental sources. The model also allows ge-
netic and environmental parameters for the unique variance
for each variable. Figure 1 displays the model and the esti-
mates of the parameters. The total variance of the latent and
the observed variables (oligomenorrhea, acne, and hirsut-
ism) is constrained to be 1. The parameter estimates (from the
best model) are depicted in Fig. 1. The percentage of the total
variance is given between parentheses. This model, which has
a larger statistical power to distinguish between genetic and
common environmental influences on familial resemblance
than the univariate model, clearly shows the importance of
genetic factors to PCOS. Heritability is estimated at 79%, and
there is no influence of common family environment.
Discussion
To our knowledge this is the first quantitative estimation
of the genetic influence on the pathogenesis of PCOS using
twin data. The prevalence of PCOS was the same for MZ
TABLE 2. Twin and sibling correlations (95% CI) for
oligomenorrhea (less than nine menstrual cycles in a year), acne,
hirsutism, and PCOS (defined as less than nine menstrual cycles
per year and acne or hirsutism)
MZF
r (95% CI)
DZF/sisters
r (95% CI)
Oligomenorrhea 0.67 (0.49 to 0.80) 0.07 (0.19 to 0.34)
Acne 0.78 (0.69 to 0.84) 0.44 (0.30 to 0.56)
Hirsutism 0.86 (0.75 to 0.92) 0.28 (0.05 to 0.50)
PCOS 0.71 (0.43 to 0.88) 0.38 (0.00 to 0.66)
MZF, Monozygotic females; DZF/sisters, dizygotic females twins
and nontwin sisters.
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twins, DZ twins, and singleton sisters. However, the prev-
alence in our sample was slightly lower than reported in
other population studies (1–3). It is possible that the preva-
lence of PCOS is lower in families that produced twins.
However, the prevalence in female spouses of male twins (in
general not coming from twin families) is 2.3% (n  5 of 215
subjects), which suggests that the low prevalence in our
sample is not the result of selecting twin families. The prev-
alence is in line with a Dutch cross-sectional population-
based study in adolescents (being more than 3 yr after men-
arche), which indicated a prevalence of about 3% of
oligomenorrhea combined with signs of hyperandrogenism
(24). Whether the low prevalences are due to lifestyle dif-
ferences in The Netherlands, compared with other countries,
or to other factors, is unknown.
We did not include ultrasound criteria in the definition of
PCOS but relied on self-reported items on oligomenorrhea,
hirsutism, and acne. This is very much analogous to the link
between oligomenorrhea and cardiovascular diseases form
the Nurse’s Health Study (25). Epidemiological studies have
shown that oligomenorrhea, hirsutism, and acne are very
good indicators of PCOS in the general population (14).
Our study points to a strong contribution of genetic factors
to PCOS and indicates that a model including additive ge-
netic factors and unique environmental factors is the most
parsimonious. In this model the variance in the pathogenesis
of PCOS is for 72% due to genetic influences. The high her-
itability was confirmed by the results from the multivariate
genetic analysis, which has a larger power to detect genetic
influences (26).
There are few data regarding PCOS in twins. Jahanfar et
al. (27) studied 34 twin pairs (19 MZ and 15 DZ) from an
original group of 500 twin pairs that volunteered for PCOS-
related ultrasonographic, clinical, and biochemical evalua-
tion.Of the 68 individuals, 33 hadPCOovaries on ultrasound
scan, 19 had acne, 12 were hirsute, and seven had oligo/
amenorrhea. Eleven pairs were discordant for PCO ovaries
on ultrasound scan (five were MZ and six were DZ twins).
From this small study they concluded that PCOS is not the
result of a single autosomal genetic defect but that PCOSmay
be the result of polygenic factors or that environmental fac-
tors are involved in the pathogenesis of this disorder (27).
Several other studies showed that there appears to be
evidence for a genetic component in PCOS based on familial
clustering of cases (7, 8, 15). In most family studies, the
number of participants is small and PCOS was defined in
different ways. In accordance with the Rotterdam consensus
(4), we defined PCOS as less than nine natural menstrual
cycles a year combined with hirsutism or acne. No ultra-
sound data were available.
The twin correlations for oligomenorrhea, hirsutism, and
acne showed that these variables are largely influenced by
genetic factors because the MZ twin correlation was (more
than) twice the DZ/sister correlation. Noteworthy, the DZ
correlation for oligomenorrhea is less than twice the MZ
correlation, indicating that nonadditive genetic influences
play an important role. The results are in accordance with
other studies. For example, in 2002 Bataille et al. (28) showed
that 81% of the variance in acne was attributable to additive
genetic effects, whereas the remaining 19% were attributed
to unique environmental factors. Previous studies also
showed that androgen levels and androgen production rates
in humans are under genetic control (29).
In a further step, we modeled the three variables, oligo-
menorrhea, acne, and hirsutism, in an independent pathway
model. Thismodel confirmed our findingwith the univariate
analyses: the latent variable (PCOS)was highly influenced by
genetic variance (79%) and unique environmental influence
(21%). Shared environmental influence did not contribute to
the latent variable. The results point to the importance of
genetic involvement in PCOS and justify the continuous ef-
fort to trace the responsible genes. This has been relatively
unsuccessful so far, probably due to a number of reasons.
Onemajor problem remains: the definition of the phenotype.
For example, the most recently developed guideline allows
for no less than four possibly distinct phenotypes (3). An-
other problem is the underlying complexity of the disorder.
The metabolic nature of PCOS with combined dysregulation
of carbohydrate and fat metabolism and abnormal steroid
hormone secretion (9) has led to the suggestion of numerous
candidate genes. For a detailed update on this, we referred
to several recently published overviews (10–12). Additional
difficulties are the lack of a clear male phenotype and PCOS
being a major cause of female infertility (9). Finally, envi-
ronmental factors are also of importance. Environmental fac-
tors, i.e. weight gain, may trigger the development of PCOS
in predisposed women (10–12). The environmental factors
may vary between populations andmay actually themselves
include a genetic component (30).
Currently a prevailing view is that genetic compounds
account for disturbed regulation of ovarian androgenic ac-
tivity and that environmental circumstances that are of in-
fluence on glucose/insulin household predominantly act by
aggravating the syndrome through hyperinsulinism and in-
sulin resistance (10–12).
In summary, a number of studies have shown familial
TABLE 3. Model-fitting results for PCOS defined as less than nine menstrual cycles and acne or hirsutism
Model 2LL Df df 2 P AIC a2, % c2, % e2, %
1. ACE 803.116 3196 66 5 29
2. AE 803.138 3197 1 0.023 0.880 1.94 72 28
3. CE 805.845 3197 1 2.729 0.099 0.73 55 45
4. E 827.258 3198 2 24.142 0.000 20.14 100
A lower value of AIC indicates a more parsimonious model. A, Additive genetic influences; C, common environmental influences; E, unique
environmental factors; 2LL, 2 log likelihood; df, degrees of freedom; df, difference in degrees of freedom; a2, percent of variance explained
by additive genetic influences (heritability); c2, percent of variance explained by common environment; e2, percent of variance explained by
unique environmental influences.
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aggregation for PCOS, but less was known about the mag-
nitude of a genetic effect, and the putative PCOS genes have
not yet been identified. The present study points to a strong
contribution of genetic factors to the pathogenesis of PCOS,
justifying further search for these susceptibility genes.
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